GRTS - Gritstone Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GRTS is currently covered by 4 analysts with an average price target of $0.92. This is a potential upside of $0.87 (1740%) from yesterday's end of day stock price of $0.05.

Gritstone Oncology's activity chart (see below) currently has 4 price targets and 13 ratings on display. The stock rating distribution of GRTS is 90.91% BUY and 9.09% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.38% with an average time for these price targets to be met of 73.33 days.

Highest price target for GRTS is $6, Lowest price target is $6, average price target is $0.92.

Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 07-Dec-2023. First documented stock forecast 11-Dec-2018.

Best performing analysts who are covering GRTS - Gritstone Oncology:

Thomas Shrader Madhu Kumar Corinne Jenkins Sean Lee Edward Tenthoff Mayank Mamtani

Currently out of the existing stock ratings of GRTS, 10 are a BUY (90.91%), 1 are a SELL (9.09%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$4.99 (494.06%)

$8

10 months 5 days ago

0/2 (0%)

$4.38 (270.37%)

Buy

$7

$5.99 (593.07%)

$6

1 years 14 days ago

0/2 (0%)

$5.44 (348.72%)

Buy

$7

$5.99 (593.07%)

$7

1 years 2 months 2 days ago

1/7 (14.29%)

$5.18 (284.62%)

5

Sell

$2

$0.99 (98.02%)

$15

2 years 1 months 20 days ago

1/2 (50%)

$-1.74 (-46.52%)

267

Buy

$35

2 years 11 months 27 days ago

0/2 (0%)

$9.45 (36.99%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GRTS (Gritstone Oncology) average time for price targets to be met?

On average it took 73.33 days on average for the stock forecasts to be realized with a an average price target met ratio 27.38

Which analyst has the current highest performing score on GRTS (Gritstone Oncology) with a proven track record?

THOMAS SHRADER

Which analyst has the current lower performing score on GRTS (Gritstone Oncology) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on GRTS (Gritstone Oncology)?

Thomas Shrader works at BTIG and has 10 price targets and 8 ratings on GRTS

Which analyst is the currently most bullish on GRTS (Gritstone Oncology)?

Edward Tenthoff with highest potential upside - $5.99

Which analyst is the currently most reserved on GRTS (Gritstone Oncology)?

Thomas Shrader with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?